Malina, Mel G.

HRN: 09-05-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFTRIAXONE 1G (VIAL)
11/07/2023
11/14/2023
IV
1g
Q12
Degloving Injury
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: